Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial.

Méndez-Sánchez, Nahum; González, Verónica; Chávez-Tapia, Norberto; Ramos, Martha H; Uribe, Misael

Méndez-Sánchez, Nahum; González, Verónica; Chávez-Tapia, Norberto; Ramos, Martha H; Uribe, Misael.

Affiliation

Méndez-Sánchez N; Department of Biomedical Research, Liver Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico. nmendez@medicasur.org.mx

Ann Hepatol ; 3(3): 108-12, 2004.

Article in En | MEDLINE | ID: mdl-15505596

Subject(s)

Cholagogues and Choleretics/administration & dosage; Fatty Liver/drug therapy; Fatty Liver/metabolism; Ursodeoxycholic Acid/administration & dosage; Weight Loss/drug effects; Adult; Diet, Reducing; Double-Blind Method; Fatty Liver/diet therapy; Female; Humans; Middle Aged; Obesity/diet therapy; Obesity/metabolism; Placebos

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ursodeoxycholic Acid / Cholagogues and Choleretics / Weight Loss / Fatty Liver Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Hepatol Journal subject: GASTROENTEROLOGIA Year: 2004 Document type: Article Affiliation country: Mexico Country of publication: Mexico

Search on Google

Add to My VHL

XML

PubMed Links